Albemarle topped analyst expectations with a narrower second-quarter loss and higher sales. The stock gained 7% to $73.35 after the market closed Wednesday.
Align Technology missed on second-quarter results and said it has plans to reduce its workforce. The maker of Invisalign is seeing more patients hold off on starting orthodontic treatment, or choose the cheaper metal braces option instead. Shares plummeted 38% to $127.49 in after-hours trading.
F5 posted higher earnings, boosted by a jump in software demand tied to AI adoption. Shares rose 8% to $322.11 in late trade.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
July 30, 2025 19:30 ET (23:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.